Related references
Note: Only part of the references are listed.Cancer Statistics, 2012
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2012)
Bcl-XL and STAT3 mediate malignant actions of γ-irradiation in lung cancer cells
Jin-Nyoung Ho et al.
CANCER SCIENCE (2010)
Acquired radioresistance of human tumor cells by DNA-PK/AKT/GSK3β-mediated cyclin D1 overexpression
T. Shimura et al.
ONCOGENE (2010)
Down-regulation of survivin by oxaliplatin diminishes radioresistance of head and neck squamous carcinoma cells
Zakir Khan et al.
RADIOTHERAPY AND ONCOLOGY (2010)
Combined Bcl-2/Mammalian Target of Rapamycin Inhibition Leads to Enhanced Radiosensitization via Induction of Apoptosis and Autophagy in Non-Small Cell Lung Tumor Xenograft Model
Kwang Woon Kim et al.
CLINICAL CANCER RESEARCH (2009)
AT-101, a small molecule inhibitor of anti-apoptotic Bcl-2 family members, activates the SAPK/JNK pathway and enhances radiation-induced apoptosis
Shuraila F. Zerp et al.
RADIATION ONCOLOGY (2009)
Alteration of the mitochondrial apoptotic pathway is key to acquired paclitaxel resistance and can be reversed by ABT-737
Ozgur Kutuk et al.
CANCER RESEARCH (2008)
Downregulation of BCL-2 induces downregulation of carbonic anhydrase IX, vascular endothelial growth factor, and pAkt and induces radiation sensitization
Satoshi Anai et al.
UROLOGY (2007)
BH3 profiling identifies three distinct classes of apoptotic blocks to predict response to ABT-737 and conventional chemotherapeutic agents
Jing Deng et al.
CANCER CELL (2007)
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
T Oltersdorf et al.
NATURE (2005)
Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial
J Ragaz et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Epidermal growth factor receptor and response of head-and-neck carcinoma to therapy
KK Ang et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2004)
Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation.
H Bartelink et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Share Paper
